Design
Review
Loading...
Supports individualized CCB selection by pharmacologic profile; leaves open prospective validation of specific applications.
The chemical heterogeneity of calcium-channel antagonists dictates their pharmacologic diversity and specific clinical applications in cardiovascular medicine.
A 1992 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: